Research coauthored by RTI Health Solutions researchers will be presented at AMCP Nexus 2019. In addition, David Wamble will be moderating the CPE session, “The Times They Are a-Changin" – A Look at Congressional Efforts to Reform the Medicare and Medicaid Prescription Drug Programs.
Cost-effectiveness and budget impact of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis using 2019 drug costs. Carrico J, Jia X, Zhao Y, Zhang J, Brodtkorb TH, Mendelsohn A, Wu JJ, Feldman SR, Armstrong A.
Recovery from opioid use disorder post-monthly buprenorphine extended release treatment: 12-month longitudinal outcomes. Ling W, Nadipelli V, Ronquest N, Aldridge A, Solem C, Peiper N, Learned S, Heidbreder C.
Public health and economic impact of adjuvanted recombinant zoster vaccine adoption for a large, integrated delivery network: utilizing real‐world epidemiological data in a budget impact model. Patterson BJ, Herring WL, Van Oorschot D, Curran D, Carrico J, Zhang Y, Ackerson BK, Bruxvoort K, Sy LS, Tseng HF.
“The Times They Are a-Changin" – A Look at Congressional Efforts to Reform the Medicare and Medicaid Prescription Drug Programs
Ross D. Margulies, JD, MPH; David Wamble, PhD
CPE Session [L1]
Wednesday, October 30, 2019
10:15 AM - 11:45 AM
Location: Potomac D
David Wamble, Shahnaz Khan, and Dave Fontaine will be attending this conference. If you'd like to connect with one of them, click on their name below to contact them.